The combination of magnetic beads with SERS-based detection was firstly reported by Sha et al. (2008), where the bead modified with anti-EpCAM antibody and SERS nanotags with anti-HER2 were used for specific recognition of breast cancer cells in whole blood. Here, ERBB2 is linked to breast cancer.